Why Recursion Pharmaceuticals, Inc.’s (RXRX) Stock Is Up 13.10% By Cynthia McLaughlin February 17, 2026 Featured Tickers: RXRX ...

Christmas has come and gone, kids are back in school and adults are returning to the 9-to-5. Does that mean holiday decor should come down? According to one tradition, now is the perfect time to take ...

This story is free to read because readers choose to support LAist. If you find value in independent local reporting, make a donation to power our newsroom today. If you celebrated Christmas this year ...

It was one Christmas visitor that didn’t overstay its welcome. A Burmese python that had been spotted in a Miami-Dade neighborhood was removed just days before Christmas after a resident out for a ...

On CNBC's “Mad Money Lightning Round,” on Thursday, Jim Cramer said Recursion Pharmaceuticals (NASDAQ: RXRX) has been “horrendous” and he does not like to recommend horrendous stocks. On the earnings ...

The Rockefeller Center Christmas tree was hoisted aloft at its new home in Manhattan on Saturday, marking the start of New York City’s holiday season. This year’s tree is a 75-foot-tall Norway spruce ...

This tree could be the Rockefeller Center Christmas tree! Many have spotted a towering tree — whether in their community, down their block or even on their property — that seemed large enough, full ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...